Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kewaunee Scientific (KEQU) Current Deferred Revenue (2016 - 2025)

Historic Current Deferred Revenue for Kewaunee Scientific (KEQU) over the last 15 years, with Q4 2025 value amounting to $4.3 million.

  • Kewaunee Scientific's Current Deferred Revenue fell 3040.55% to $4.3 million in Q4 2025 from the same period last year, while for Oct 2025 it was $4.3 million, marking a year-over-year decrease of 3040.55%. This contributed to the annual value of $6.1 million for FY2025, which is 3884.32% up from last year.
  • Per Kewaunee Scientific's latest filing, its Current Deferred Revenue stood at $4.3 million for Q4 2025, which was down 3040.55% from $5.0 million recorded in Q3 2025.
  • Kewaunee Scientific's Current Deferred Revenue's 5-year high stood at $14.1 million during Q3 2022, with a 5-year trough of $2.6 million in Q3 2021.
  • In the last 5 years, Kewaunee Scientific's Current Deferred Revenue had a median value of $4.9 million in 2023 and averaged $5.7 million.
  • Its Current Deferred Revenue has fluctuated over the past 5 years, first skyrocketed by 45248.53% in 2022, then crashed by 5684.33% in 2023.
  • Kewaunee Scientific's Current Deferred Revenue (Quarter) stood at $3.1 million in 2021, then soared by 273.46% to $11.4 million in 2022, then tumbled by 56.84% to $4.9 million in 2023, then increased by 26.83% to $6.2 million in 2024, then crashed by 30.41% to $4.3 million in 2025.
  • Its Current Deferred Revenue stands at $4.3 million for Q4 2025, versus $5.0 million for Q3 2025 and $6.1 million for Q2 2025.